“
Miroslav Trinko Geek, specialty programmer, but journalist by profession. Rider, tennis player and fan of Formula-1. I write about technologies, smartphones and electric vehicles.
According to the publication, the subject of negotiation became the project Cdergpt – AI tool, which is probably designed for the Center for Drug Evaluration (CDE), FDA, which is responsible for regulating both prescription and over -the -counter drugs in the United States.
It is also noted that the discussions were joined by DOGE representatives – structures related to Ilon Musk.
Wired emphasizes that the full cycle of new medicines is often over ten years. Openai technologies can help reduce at least part of this process – especially in the final stages.
AI has long been regarded as a promising tool for optimizing certain stages of pharmaceutical research, but there are questions about the accuracy of such models and control of possible mistakes.
”, – WRITE: mezha.media
Miroslav Trinko Geek, specialty programmer, but journalist by profession. Rider, tennis player and fan of Formula-1. I write about technologies, smartphones and electric vehicles.
According to the publication, the subject of negotiation became the project Cdergpt – AI tool, which is probably designed for the Center for Drug Evaluration (CDE), FDA, which is responsible for regulating both prescription and over -the -counter drugs in the United States.
It is also noted that the discussions were joined by DOGE representatives – structures related to Ilon Musk.
Wired emphasizes that the full cycle of new medicines is often over ten years. Openai technologies can help reduce at least part of this process – especially in the final stages.
AI has long been regarded as a promising tool for optimizing certain stages of pharmaceutical research, but there are questions about the accuracy of such models and control of possible mistakes.